EATRIS Annual Report 2017

The future of Translational Medicine by Toni Andreu

A Retrospective look at EATRIS during its first 5 years

Successful RItrain Knowledge Exchange workshop hosted by EATRIS

Public consultation: Evaluation of the European Medicines Agency Fee System

Unique hub collaboration – Imaging method development in inflammatory diseases

Long term partnership between EATRIS sites and GSK.

ECaDE interview published online

Win a trip to Down Under including your ticket to AusBiotech 2018

CORBEL 2nd Open Call: Apply for Research Infrastructures Services

Transnational network for personalised medicine launches

EMA releases draft guideline on Safety and Efficacy (S&E) follow-up, and risk management for Advanced Therapy Medicinal Products (ATMPs).

EMA updates procedural advice to clarify regulatory process for Advanced Therapy Medicinal Products

ID-EPTRI: a new research infrastructure for better paediatric medicines emerges

2nd open call for RItrain knowledge exchange – profit from the expertise of other Research Infrastructures

New funding opportunity for neurodegenerative disease launched by NeurATRIS

Sweden begins the year by becoming a full member

Five reasons not to miss EMA’s Awareness Sessions, this March

National PET Center in Turku signs collaboration agreement to develop imaging for tissue fibrosis research, with help from EATRIS